Literature DB >> 5540164

Serum cholesterol esterifying and cholesteryl ester hydrolyzing activities in liver diseases: relationships to cholesterol, bilirubin, and bile salt concentrations.

D P Jones, F R Sosa, J Shartsis, P T Shah, E Skromak, W T Beher.   

Abstract

Patients with acute hepatitis and chronic alcoholic liver disease had decreased net serum cholesterol esterifying activity (CEA) which correlated positively with the percentages and concentrations of cholesteryl esters in their serum. These cholesterol parameters also correlated negatively with serum bilirubin concentrations, but bilirubin added to sera in vitro failed to influence CEA. The decreased net CEA in the patients was not due to its inhibition by serum bile salts. The sera from five patients catalyzed a net hydrolysis of cholesteryl esters rather than a net esterification of free cholesterol. Since serum cholesteryl ester hydrolase activity may also have been present in the patients with decreased CEA, net CEA cannot be equated with the activity of lecithin-cholesterol acyl transferase (LCAT) in patients with liver disease. The relative contributions of LCAT and cholesteryl ester hydrolase activities to CEA in disease states remain to be evaluated by mutually independent assays. Nevertheless, the correlations found between net CEA and the concentrations and percentages of cholesteryl esters support the concepts that serum cholesterol esterifying activity is physiologically important in the formation of serum cholesteryl esters and that decreased CEA is one mechanism for the decreased level of cholesteryl esters seen in patients with liver diseases.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5540164      PMCID: PMC291919          DOI: 10.1172/JCI106490

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  8 in total

1.  The mechanism of the plasma cholesterol esterification reaction: plasma fatty acid transferase.

Authors:  J A GLOMSET
Journal:  Biochim Biophys Acta       Date:  1962-11-19

2.  [Cholesterol-esterase activity in hepatopathies].

Authors:  A BERTOLINI; C GUARDAMAGNA
Journal:  Acta Vitaminol       Date:  1959-02

3.  Studies of liver function tests. III. Dependence of percentage cholesterol esters upon the degree of jaundice.

Authors:  L ZIEVE
Journal:  J Lab Clin Med       Date:  1953-07

4.  The cholesterol-esterifying enzyme of human serum. I. In liver disease.

Authors:  K B TURNER; G H McCORMACK; A RICHARDS
Journal:  J Clin Invest       Date:  1953-09       Impact factor: 14.808

5.  A revision of the Schoenheimer-Sperry method for cholesterol determination.

Authors:  W M SPERRY; M WEBB
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

Review 6.  Cholesterol ester metabolism.

Authors:  D S Goodman
Journal:  Physiol Rev       Date:  1965-10       Impact factor: 37.312

Review 7.  The plasma lecithins:cholesterol acyltransferase reaction.

Authors:  J A Glomset
Journal:  J Lipid Res       Date:  1968-03       Impact factor: 5.922

8.  Sex differences in plasma cholesterol-esterifying activity in rats.

Authors:  L Aftergood; R B Alfin-Slater
Journal:  J Lipid Res       Date:  1967-03       Impact factor: 5.922

  8 in total
  8 in total

1.  BIOCHEMISTRY OF SERUM AND BILE CHOLELITHIASIS: Author's Reply.

Authors: 
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  STUDY OF SERUM AND BILE FROM PATIENTS OF CHOLELITHIASIS IN NORTH-EASTERN INDIA.

Authors:  P Krishna Menon; S Mahapatra
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease.

Authors:  R A Cooper; M Diloy Puray; P Lando; M S Greenverg
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

Review 4.  Current Status of Familial LCAT Deficiency in Japan.

Authors:  Masayuki Kuroda; Hideaki Bujo; Koutaro Yokote; Takeyoshi Murano; Takashi Yamaguchi; Masatsune Ogura; Katsunori Ikewaki; Masahiro Koseki; Yasuo Takeuchi; Atsuko Nakatsuka; Mika Hori; Kota Matsuki; Takashi Miida; Shinji Yokoyama; Jun Wada; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-04-18       Impact factor: 4.928

5.  Circulating sterols as predictors of early allograft dysfunction and clinical outcome in patients undergoing liver transplantation.

Authors:  Uta Ceglarek; Kathleen Kresse; Susen Becker; Georg Martin Fiedler; Joachim Thiery; Markus Quante; Robert Wieland; Michael Bartels; Gabriela Aust
Journal:  Metabolomics       Date:  2016-10-24       Impact factor: 4.290

6.  Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality.

Authors:  Thorsten Kaiser; Benedict Kinny-Köster; Michael Bartels; Thomas Berg; Markus Scholz; Cornelius Engelmann; Daniel Seehofer; Susen Becker; Uta Ceglarek; Joachim Thiery
Journal:  BMC Gastroenterol       Date:  2017-04-20       Impact factor: 3.067

Review 7.  Studies on cholesterol ester formation and hydrolysis in liver disease: a selective review.

Authors:  J B Simon
Journal:  Yale J Biol Med       Date:  1979 Jan-Feb

8.  Comparative Analyses of QTLs Influencing Obesity and Metabolic Phenotypes in Pigs and Humans.

Authors:  Sameer D Pant; Peter Karlskov-Mortensen; Mette J Jacobsen; Susanna Cirera; Lisette J A Kogelman; Camilla S Bruun; Thomas Mark; Claus B Jørgensen; Niels Grarup; Emil V R Appel; Ehm A A Galjatovic; Torben Hansen; Oluf Pedersen; Maryse Guerin; Thierry Huby; Philipppe Lesnik; Theo H E Meuwissen; Haja N Kadarmideen; Merete Fredholm
Journal:  PLoS One       Date:  2015-09-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.